Company Qiagen N.V.

Equities

QGEN

NL0015001WM6

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 04:00:02 2024-12-03 pm EST			5-day change	1st Jan Change
43.29 ^USD	-0.82%		+0.12%	-3.31%

Nov. 29	Qiagen Plans to Open New Facility in Spain in 2026	MT
Nov. 27	QIAGEN Launches Novel Tools for Customizing Digital PCR Assays and NGS Panels for Microbial Analysis	CI

Business description: Qiagen N.V.

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Number of employees: 5,800

Sales by Activity: Qiagen N.V.

Fiscal Period: December	2019	2020	2021	2022	2023
Medical Products	1.53B	1.87B	2.25B	2.14B	1.97B

See all business segments

Geographical breakdown of sales: Qiagen N.V.

Fiscal Period: December	2019	2020	2021	2022	2023
United States	664M	729M	910M	910M	935M
Europe, Middle East and Africa	487M	682M	814M	733M	625M
Asia Pacific, Japan and Rest of World	317M	363M	430M	410M	321M
Other Americas	58.12M	96.88M	97.69M	88.14M	84.77M

See all geographic segments

Managers: Qiagen N.V.

Director	Title	Age	Since
Thierry Bernard CEO	Chief Executive Officer	60	2019-10-06
Roland Sackers DFI	Director of Finance/CFO	56	2003-12-31
Antonio Santos COO	Chief Operating Officer	-	2022-03-31
Philipp von Hugo CMP	Compliance Officer	57	2003-11-30
Lezette Young CMP	Compliance Officer	-	-

See QIAGEN N.V. governance

Members of the board: Qiagen N.V.

Manager	Title	Age	Since
Metin Colpan BRD	Director/Board Member	69	2003-12-31
Elizabeth Tallett BRD	Director/Board Member	75	2011-05-31
Lawrence Rosen CHM	Chairman	67	2020-08-20
Elaine Mardis BRD	Director/Board Member	62	2013-12-31
Ross Levine BRD	Director/Board Member	52	2015-12-31
Toralf Haag BRD	Director/Board Member	58	2021-01-07
Eva Pisa BRD	Director/Board Member	70	2022-06-22
Stephen Rusckowski BRD	Director/Board Member	67	2023-04-20
Eva van Pelt BRD	Director/Board Member	59	2024-02-29
Bert van Meurs BRD	Director/Board Member	-	2024-03-31

Composition of the Board of Directors

Shareholders: Qiagen N.V.

Name	Equities	%	Valuation
Massachusetts Financial Services Co. 10.42 %	23,117,292	10.42 %	973 M $
Wellington Trust Co., NA 9.579 %	21,250,943	9.579 %	895 M $
Vanguard Fiduciary Trust Co. 3.968 %	8,801,970	3.968 %	371 M $
CPR Asset Management SA 2.638 %	5,851,275	2.638 %	246 M $
BlackRock Advisors LLC 2.371 %	5,260,407	2.371 %	221 M $

List of QIAGEN N.V. shareholders

Company details: Qiagen N.V.

QIAGEN NV

Hulsterweg 82

5912 PL, Venlo

+31 77 355 6600

http://www.qiagen.com

Group companies: Qiagen N.V.

Name	Category and Sector
Qiagen Hamburg GmbH Qiagen Hamburg GmbH Medical/Nursing ServicesHealth Services Part of QIAGEN NV, QIAGEN Hamburg GmbH is a German company that delivers sample to insights solutions, enabling customers to unlock insights from the building blocks of life - DNA, RNA, and proteins. The company is based in Hilden, Germany. The CEOs are Peer Michael Schatz and Roland Sackers. The company was founded in 2013.	Medical/Nursing Services
QIAGEN Distribution BV
QAGEN US Finance, Inc.
QIAGEN Lake Constance GmbH QIAGEN Lake Constance GmbH Electronic ComponentsElectronic Technology QIAGEN Lake Constance GmbH develops and produces optical measurement devices for medical, environmental and industrial applications. The company was founded by Thomas Wiest, Klaus Haberstroh, Roland Sackers, Peer Michael Schatz, and Jörg Schickedanz in 1997 and is headquartered in Stockach, Germany.	Electronic Components
QIAGEN Instruments AG QIAGEN Instruments AG Medical SpecialtiesHealth Technology QIAGEN Instruments AG engages in the development, production, and distribution of analytical instruments and devices. It also acquires participating interests in firms, as well as acquires and utilizes patents, licenses, and other rights. The company was founded on February 28, 1990 and is headquartered in Hombrechtikon, Switzerland.	Medical Specialties

See all subsidiaries

Other Biotechnology & Medical Research

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
QIAGEN N.V.	-0.82%	+0.12%	+1.31%	-22.53%	9.62B
LONZA GROUP AG	+0.10%	+1.70%	+59.29%	-25.55%	42.79B
IQVIA HOLDINGS INC.	-0.60%	-0.32%	-7.53%	-23.35%	36.41B
CELLTRION, INC.	+1.25%	+6.44%	+14.59%	-5.81%	27.1B
ICON PUBLIC LIMITED COMPANY	-0.27%	+0.40%	-20.92%	-21.93%	17.58B
MODERNA, INC.	-3.80%	+1.26%	-46.66%	-86.12%	16.39B
UNITED THERAPEUTICS CORPORATION	-0.36%	-2.18%	+53.20%	+98.28%	16.46B
BIO-TECHNE CORPORATION	-1.28%	+0.24%	+16.23%	-34.19%	11.92B
MEDPACE HOLDINGS, INC.	-0.90%	+1.21%	+23.19%	+64.58%	10.52B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.97%	+0.78%	-1.18%	-44.23%	10.19B
Average	-0.20%	+0.47%	+9.15%	-10.08%	19.9B
Weighted average by Cap.	+0.06%	+0.44%	+14.27%	-13.44%